Logo image of AZT.OL

ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:AZT - NO0010014632 - Common Stock

22.1 NOK
+0.6 (+2.79%)
Last: 1/22/2026, 12:01:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AZT. AZT was compared to 86 industry peers in the Biotechnology industry. While AZT has a great health rating, its profitability is only average at the moment. AZT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • AZT had positive earnings in the past year.
  • AZT had a positive operating cash flow in the past year.
  • Each year in the past 5 years AZT has been profitable.
  • AZT had a positive operating cash flow in each of the past 5 years.
AZT.OL Yearly Net Income VS EBIT VS OCF VS FCFAZT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

  • With a decent Return On Assets value of 2.17%, AZT is doing good in the industry, outperforming 79.07% of the companies in the same industry.
  • With a decent Return On Equity value of 2.32%, AZT is doing good in the industry, outperforming 77.91% of the companies in the same industry.
Industry RankSector Rank
ROA 2.17%
ROE 2.32%
ROIC N/A
ROA(3y)6.16%
ROA(5y)14.45%
ROE(3y)6.81%
ROE(5y)16.43%
ROIC(3y)N/A
ROIC(5y)N/A
AZT.OL Yearly ROA, ROE, ROICAZT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.43%, AZT belongs to the top of the industry, outperforming 81.40% of the companies in the same industry.
  • AZT's Profit Margin has declined in the last couple of years.
  • AZT's Gross Margin of 95.42% is amongst the best of the industry. AZT outperforms 95.35% of its industry peers.
  • In the last couple of years the Gross Margin of AZT has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 7.43%
GM 95.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-39.27%
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-0.64%
AZT.OL Yearly Profit, Operating, Gross MarginsAZT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

  • AZT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AZT has more shares outstanding
  • Compared to 5 years ago, AZT has more shares outstanding
  • Compared to 1 year ago, AZT has an improved debt to assets ratio.
AZT.OL Yearly Shares OutstandingAZT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AZT.OL Yearly Total Debt VS Total AssetsAZT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • AZT has an Altman-Z score of 30.55. This indicates that AZT is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of AZT (30.55) is better than 97.67% of its industry peers.
  • The Debt to FCF ratio of AZT is 0.34, which is an excellent value as it means it would take AZT, only 0.34 years of fcf income to pay off all of its debts.
  • AZT has a better Debt to FCF ratio (0.34) than 90.70% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that AZT is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.01, AZT is doing good in the industry, outperforming 77.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.34
Altman-Z 30.55
ROIC/WACCN/A
WACC8.51%
AZT.OL Yearly LT Debt VS Equity VS FCFAZT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • AZT has a Current Ratio of 16.35. This indicates that AZT is financially healthy and has no problem in meeting its short term obligations.
  • AZT has a Current ratio of 16.35. This is amongst the best in the industry. AZT outperforms 97.67% of its industry peers.
  • AZT has a Quick Ratio of 15.45. This indicates that AZT is financially healthy and has no problem in meeting its short term obligations.
  • AZT's Quick ratio of 15.45 is amongst the best of the industry. AZT outperforms 97.67% of its industry peers.
Industry RankSector Rank
Current Ratio 16.35
Quick Ratio 15.45
AZT.OL Yearly Current Assets VS Current LiabilitesAZT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

  • AZT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
  • The earnings per share for AZT have been decreasing by -43.42% on average. This is quite bad
  • Looking at the last year, AZT shows a decrease in Revenue. The Revenue has decreased by -4.73% in the last year.
  • AZT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.22% yearly.
EPS 1Y (TTM)0%
EPS 3Y-43.42%
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-6.57%
Revenue growth 5Y18.22%
Sales Q2Q%22.3%

3.2 Future

  • Based on estimates for the next years, AZT will show a very strong growth in Earnings Per Share. The EPS will grow by 73.58% on average per year.
  • Based on estimates for the next years, AZT will show a quite strong growth in Revenue. The Revenue will grow by 18.45% on average per year.
EPS Next Y-2.61%
EPS Next 2Y81.18%
EPS Next 3Y73.58%
EPS Next 5YN/A
Revenue Next Year4.69%
Revenue Next 2Y15.27%
Revenue Next 3Y16.06%
Revenue Next 5Y18.45%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AZT.OL Yearly Revenue VS EstimatesAZT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
AZT.OL Yearly EPS VS EstimatesAZT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 184.17 indicates a quite expensive valuation of AZT.
  • Based on the Price/Earnings ratio, AZT is valued a bit cheaper than 74.42% of the companies in the same industry.
  • AZT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.32.
  • A Price/Forward Earnings ratio of 48.09 indicates a quite expensive valuation of AZT.
  • Based on the Price/Forward Earnings ratio, AZT is valued a bit cheaper than the industry average as 74.42% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 24.30. AZT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 184.17
Fwd PE 48.09
AZT.OL Price Earnings VS Forward Price EarningsAZT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • 72.09% of the companies in the same industry are more expensive than AZT, based on the Enterprise Value to EBITDA ratio.
  • AZT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AZT is cheaper than 80.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 62.07
EV/EBITDA 123.63
AZT.OL Per share dataAZT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • AZT's earnings are expected to grow with 73.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.18%
EPS Next 3Y73.58%

0

5. Dividend

5.1 Amount

  • No dividends for AZT!.
Industry RankSector Rank
Dividend Yield 0%

ARCTICZYMES TECHNOLOGIES ASA

OSL:AZT (1/22/2026, 12:01:00 PM)

22.1

+0.6 (+2.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)02-11
Inst Owners15.37%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap1.13B
Revenue(TTM)103.07M
Net Income(TTM)7.66M
Analysts80
Price Target33.66 (52.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)122.77%
Min EPS beat(2)48.51%
Max EPS beat(2)197.03%
EPS beat(4)3
Avg EPS beat(4)315.98%
Min EPS beat(4)-269.73%
Max EPS beat(4)1288.12%
EPS beat(8)3
Avg EPS beat(8)125.03%
EPS beat(12)5
Avg EPS beat(12)89.53%
EPS beat(16)7
Avg EPS beat(16)63.69%
Revenue beat(2)1
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-5.88%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-3.61%
Min Revenue beat(4)-13.1%
Max Revenue beat(4)2.64%
Revenue beat(8)2
Avg Revenue beat(8)-6.86%
Revenue beat(12)3
Avg Revenue beat(12)-6.52%
Revenue beat(16)5
Avg Revenue beat(16)-3.33%
PT rev (1m)0%
PT rev (3m)17.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.7%
Valuation
Industry RankSector Rank
PE 184.17
Fwd PE 48.09
P/S 10.95
P/FCF 62.07
P/OCF 51.38
P/B 3.42
P/tB 3.81
EV/EBITDA 123.63
EPS(TTM)0.12
EY0.54%
EPS(NY)0.46
Fwd EY2.08%
FCF(TTM)0.36
FCFY1.61%
OCF(TTM)0.43
OCFY1.95%
SpS2.02
BVpS6.47
TBVpS5.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.18
Profitability
Industry RankSector Rank
ROA 2.17%
ROE 2.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 7.43%
GM 95.42%
FCFM 17.64%
ROA(3y)6.16%
ROA(5y)14.45%
ROE(3y)6.81%
ROE(5y)16.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-39.27%
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-0.64%
F-Score7
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.34
Debt/EBITDA 0.7
Cap/Depr 42.8%
Cap/Sales 3.67%
Interest Coverage N/A
Cash Conversion 352.73%
Profit Quality 237.39%
Current Ratio 16.35
Quick Ratio 15.45
Altman-Z 30.55
F-Score7
WACC8.51%
ROIC/WACCN/A
Cap/Depr(3y)231.16%
Cap/Depr(5y)215.23%
Cap/Sales(3y)11.45%
Cap/Sales(5y)9.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-43.42%
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y-2.61%
EPS Next 2Y81.18%
EPS Next 3Y73.58%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-6.57%
Revenue growth 5Y18.22%
Sales Q2Q%22.3%
Revenue Next Year4.69%
Revenue Next 2Y15.27%
Revenue Next 3Y16.06%
Revenue Next 5Y18.45%
EBIT growth 1Y-75.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year328.57%
EBIT Next 3Y149.71%
EBIT Next 5YN/A
FCF growth 1Y133.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.22%
OCF growth 3Y-71.92%
OCF growth 5Y-16%

ARCTICZYMES TECHNOLOGIES ASA / AZT.OL FAQ

What is the fundamental rating for AZT stock?

ChartMill assigns a fundamental rating of 5 / 10 to AZT.OL.


What is the valuation status of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) stock?

ChartMill assigns a valuation rating of 4 / 10 to ARCTICZYMES TECHNOLOGIES ASA (AZT.OL). This can be considered as Fairly Valued.


Can you provide the profitability details for ARCTICZYMES TECHNOLOGIES ASA?

ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for AZT stock?

The Earnings per Share (EPS) of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is expected to decline by -2.61% in the next year.